Stuart A Aaronson

8PUBLICATIONS
57CO-AUTHORS
Molecular targetsHaematological tumoursRegenerative medicine (incl. stem cells)Autoimmunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Sep 29, 2026
Spatial modulation of RAF by RAF/MEK glue enables full-dose combination with pan-RAF inhibitor and potent RAS-mutant tumor-selective MAPK and growth inhibition.

|Oct 15, 2025
RAS Mutation-Specific Responses to Paralog- and State-Selective RAS Inhibitors.

Beau Baars, Ana Orive-Ramos, Matthew J Emmett

|Aug 22, 2025
Prolonging lung cancer response to EGFR inhibition by targeting the selective advantage of resistant cells.

Lisa Brunet, David Alexandre, Jiyoung Lee

|Feb 13, 2025
Modulation of tumor inflammatory signaling and drug sensitivity by CMTM4.

Yitian Xu, Kyeongah Kang, Brian A Coakley

|Feb 05, 2022
ROCK1 mechano-signaling dependency of human malignancies driven by TEAD/YAP activation.

Davide Esposito, Ila Pant, Yao Shen

|Jan 18, 2022
Patient-specific MDS-RS iPSCs define the mis-spliced transcript repertoire and chromatin landscape of SF3B1-mutant HSPCs.

Georgios Asimomitis, André G Deslauriers, Andriana G Kotini

Pageof 2

Frequent Collaborators

4 joint publications

Poulikos I Poulikakos

3 joint publications

Ila Pant

3 joint publications

Jian Jin

2 joint publications

Mathieu Desaunay